Navin Fluorine International Limited reported a consolidated net profit after tax (PAT) of ₹243.31 crore for the quarter ended June 30, 2026 (Q1FY27), marking a 108% year-on-year surge. The strong performance was driven by a 44% rise in revenue from operations to ₹1,045.08 crore, supported by constructive pricing in hydrofluoroolefins (HFCs), scale-up of specialty chemicals, and deepened engagement with European partners in the Contract Development and Manufacturing Organization (CDMO) segment. During the earnings call on August 05, 2026, management highlighted that the company became net debt-free during the quarter, with operating cash flows standing at ₹173 crore.

The company has scheduled an analyst and institutional investor meet for August 20, 2026, at 10:00 am IST. This intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The presentation to be made at the meeting is based on publicly available information, with discussions expected to cover the recent financial results and strategic initiatives.

The results were filed with stock exchanges pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Statutory auditors Price Waterhouse Chartered Accountants LLP provided a limited review report on the unaudited financial results. Chairman Vishad Mafatlal and Managing Director Nitin Kulkarni emphasized the company’s disciplined execution strategy and its transition towards high-margin advanced materials.

Financial Highlights

Operating profitability expanded significantly, with operating EBITDA rising 73% to ₹357.07 crore, pushing the operating EBITDA margin up by 566 basis points to 34.2%. Profit before tax (PBT) jumped 105% to ₹318.36 crore. On a standalone basis, the holding company reported a net profit of ₹190.64 crore, up 69% from ₹112.76 crore in the prior year quarter, while standalone revenue increased 28% to ₹694.68 crore. Net working capital days stood at 81 days of sales.

Segment Performance

Revenue growth was broad-based across all business units:

• HPP: Revenue grew 33% YoY to ₹540 crore, supported by constructive pricing for hydrofluoroolefins (HFCs) and ramp-up of the anhydrous hydrofluoric acid (AHF) facility. Management noted that long-term demand for R32 is expected to double over the next decade while supply shrinks due to quotas.
• Specialty Chemicals: Revenue surged 48% YoY to ₹325 crore, aided by strong order visibility and scale-up of existing molecules. The company has visibility for campaign orders for four to five new molecules in the agrochemical space.
• CDMO: Revenue nearly doubled with an 82% YoY increase to ₹180 crore, driven by deeper engagement with European partners and increased demand for existing molecules. The pipeline includes three more molecules expected to go to FDA readout in the next 8 to 12 months.

Strategic Capex Approvals

The Board approved significant capital expenditures to incubate new growth verticals:

• Advanced Materials: ₹90 crore funded through internal accruals to establish adoption capacities at the Surat unit. This aims to progress products from lab scale to commercial scale qualification by Q2FY28, targeting sectors like data centers, electronics, semiconductors, and defense. This includes a technology development partnership with DRDO for an indigenous specialty material.
• CDMO Expansion: Phase 2 cGMP4 capex of ₹125 crore, also funded through internal accruals, expected to operationalize by Q4FY27. This supports growing demand from a European CDMO partner and expands the footprint in their supply chain to API minus 1 level.
• Other Projects: HFC capacity expansion equivalent to up to 15,000 metric tons of R32 remains on track for commissioning in Q3FY27. A renewable energy project investment of ₹15.73 crore for a 14.9 megawatt hybrid renewable power plant will meet more than 60% of energy requirements through renewable sources once operational.

What the Numbers Show

The divergence between revenue growth (44%) and expense management highlights improved operating leverage for Navin Fluorine International Limited. While raw material costs rose to ₹449.75 crore from ₹307.71 crore, the company successfully contained other expenses, leading to a substantial expansion in operating margins. The CDMO segment’s 82% revenue growth indicates successful execution of its strategy to deepen ties with global innovators, while the HPP segment benefits from favorable global demand-supply dynamics for low-GWP gases. The consistent quarter-on-quarter growth in PAT over the last four quarters underscores sustained operational momentum, further strengthened by the company becoming net debt-free.

Shareholders of Navin Fluorine International Limited approved a final dividend of ₹8.60 per equity share and reappointed key board members at the company’s 28th Annual General Meeting (AGM) held on August 06, 2026. The meeting, conducted via Video Conferencing / Other Audio Visual Means, concluded with all resolutions receiving the requisite majority vote, signaling continued shareholder confidence in the company’s leadership and financial distribution strategy.

The AGM commenced at 03.30 P.M. (IST) and concluded at 04.46 P.M. (IST), with the e-voting period remaining open for an additional 15 minutes until 05.01 P.M. (IST). The proceedings were held in compliance with the Companies Act, 2013, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and relevant Ministry of Corporate Affairs circulars. The results of remote e-voting and e-voting at the AGM were submitted to stock exchanges separately, as per Regulation 44(3) of the SEBI Listing Regulations and the Consolidated Scrutinizer's Report under Section 108 of the Act read with Rule 20 of the Companies (Management and Administration) Rules, 2014.

Ordinary Business Resolutions

Under ordinary business, shareholders received, considered, and adopted the Annual Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026, along with the Board’s Report and Statutory Auditors’ Report. The declaration of the final dividend of ₹8.60 per Equity Share of face value ₹2/- each for the financial year 2025-26 was also approved via ordinary resolution.

Additionally, the meeting reappointed Sudhir R. Deo (DIN: 01122338), who retires by rotation, as a Director of the Company. This reappointment was passed as an ordinary resolution.

Special Business Resolutions

The special business agenda focused on leadership continuity and auditor appointments. Shareholders passed special resolutions to reappoint Vishad P. Mafatlal (DIN: 00011350) as Executive Chairman. The board composition was further reinforced with the reappointment of Sujal A. Shah (DIN: 00058019) and Apurva S. Purohit (DIN: 00190097) as Independent Directors.

The company also ratified the remuneration of B. Desai & Co. (Firm Registration No. 005431) as Cost Auditors for the Financial Year 2026-27 through an ordinary resolution. All resolutions were duly approved by the members with the requisite majority.

What the Numbers Show

The approval of the ₹8.60 per share dividend underscores the company’s commitment to returning capital to shareholders, even as it maintains stability in its board structure. The reappointment of long-standing executives like Vishad P. Mafatlal and Sudhir R. Deo suggests a strategic focus on continuity during the upcoming fiscal year. The separate submission of voting results to exchanges ensures transparency in compliance with SEBI regulations.